Martin Bozzola

TL;DR: The WAO Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines was planned to provide physicians everywhere with a management tool to deal with CMA from suspicion to treatment and to relieve the burden of issues through an ongoing and collective effort of more interactive debate and integrated learning.

TL;DR: Alessandro Fiocchi, MD, Pediatric Division, Department of Child and Maternal Medicine, University of Milan Medical School at the Melloni Hospital, Milan 20129, Italy, and Holger Schünemann,MD, department of Clinical Epidemiology & Biostatistics, McMaster University Health Sciences Centre, 1200 Main Street West Hamilton, Ontario, Canada.

TL;DR: Pneumonitis was found in >40% of patients, presented early in life, was misdiagnosed despite chronic respiratory symptoms and accompanying radiographic and pulmonary function abnormalities, and caused hypoxemic respiratory failure and death.

TL;DR: DRACMA reconciled international differences in the diagnosis and management of CMA, promoted a cultural debate, improved clinician’s knowledge ofCMA, improved the quality of diagnosis and care, reduced inappropriate practices, fostered the efficient use of resources, empowered patients, and influenced some public policies.

TL;DR: In this paper , the authors present evidence-based guidelines from the World Allergy Organization (WAO) to support patients, clinicians, and others in decisions about the use of oral and epicutaneous immunotherapy for the treatment of IgE-mediated CMA.